HomeOGN • NYSE
add
Organon & Co
$6.33
Makalipas ang Oras ng Trabaho:(0.95%)+0.060
$6.39
Sarado: Mar 12, 5:56:47 PM GMT-4 · USD · NYSE · Disclaimer
Nakaraang pagsara
$6.40
Sakop ng araw
$6.27 - $6.48
Sakop ng taon
$6.18 - $15.88
Market cap
1.65B USD
Average na Volume
4.45M
P/E ratio
8.83
Dividend yield
1.26%
Primary exchange
NYSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.51B | -5.34% |
Gastos sa pagpapatakbo | 522.00M | -11.38% |
Net na kita | -205.00M | -288.07% |
Net profit margin | -13.60 | -298.54% |
Kita sa bawat share | 0.63 | -30.00% |
EBITDA | 340.00M | -11.46% |
Aktuwal na % ng binabayarang buwis | -38.51% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 574.00M | -14.96% |
Kabuuang asset | 12.87B | -1.79% |
Kabuuang sagutin | 12.12B | -4.07% |
Kabuuang equity | 752.00M | — |
Natitirang share | 260.32M | — |
Presyo para makapag-book | 2.21 | — |
Return on assets | 4.62% | — |
Return on capital | 6.33% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -205.00M | -288.07% |
Cash mula sa mga operasyon | 141.00M | -63.85% |
Cash mula sa pag-invest | -65.00M | 78.04% |
Cash mula sa financing | -187.00M | -128.05% |
Net change in cash | -98.00M | -11.36% |
Malayang cash flow | 64.88M | -76.36% |
Tungkol
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Itinatag
1923
Headquarters
Website
Mga Empleyado
10,000
